A detailed history of Robeco Institutional Asset Management B.V. transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Robeco Institutional Asset Management B.V. holds 179,084 shares of ADMA stock, worth $3.12 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
179,084
Previous 111,084 61.21%
Holding current value
$3.12 Million
Previous $1.24 Million 188.4%
% of portfolio
0.01%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$11.21 - $20.03 $762,280 - $1.36 Million
68,000 Added 61.21%
179,084 $3.58 Million
Q2 2024

Jul 22, 2024

BUY
$5.98 - $11.18 $664,282 - $1.24 Million
111,084 New
111,084 $1.24 Million
Q4 2022

Feb 06, 2023

BUY
$2.47 - $3.88 $27,016 - $42,439
10,938 New
10,938 $42,000

Others Institutions Holding ADMA

About ADMA BIOLOGICS, INC.


  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.42B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Robeco Institutional Asset Management B.V. Portfolio

Follow Robeco Institutional Asset Management B.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Robeco Institutional Asset Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Robeco Institutional Asset Management B.V. with notifications on news.